Antje Rottmann

864 total citations
29 papers, 654 citations indexed

About

Antje Rottmann is a scholar working on Molecular Biology, Organic Chemistry and Genetics. According to data from OpenAlex, Antje Rottmann has authored 29 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Organic Chemistry and 6 papers in Genetics. Recurrent topics in Antje Rottmann's work include Estrogen and related hormone effects (5 papers), Endometriosis Research and Treatment (4 papers) and Chemical Synthesis and Analysis (4 papers). Antje Rottmann is often cited by papers focused on Estrogen and related hormone effects (5 papers), Endometriosis Research and Treatment (4 papers) and Chemical Synthesis and Analysis (4 papers). Antje Rottmann collaborates with scholars based in Germany, United Kingdom and Norway. Antje Rottmann's co-authors include Jens Koßmann, Gerhard Ritte, Martin Steup, Nora Eckermann, James R. Lloyd, Joachim Höchel, Martin G. Peter, Ivan Jambor, B. Hofmann and Anne Roivainen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Analytical Biochemistry.

In The Last Decade

Antje Rottmann

27 papers receiving 631 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antje Rottmann Germany 12 177 173 127 108 79 29 654
Yi‐Ru Chen Taiwan 23 134 0.8× 321 1.9× 22 0.2× 178 1.6× 17 0.2× 65 1.2k
Alex Philchenkov Ukraine 14 45 0.3× 451 2.6× 43 0.3× 123 1.1× 40 0.5× 39 812
J Sedlák Slovakia 16 110 0.6× 450 2.6× 25 0.2× 175 1.6× 39 0.5× 77 837
Bianca Nitzsche Germany 17 41 0.2× 259 1.5× 36 0.3× 59 0.5× 23 0.3× 36 621
Smarajit Pal India 15 114 0.6× 228 1.3× 58 0.5× 186 1.7× 42 0.5× 27 646
Chenghua Li China 13 62 0.4× 366 2.1× 226 1.8× 196 1.8× 38 0.5× 36 826
Rajeshwari R. Mehta United States 19 26 0.1× 635 3.7× 138 1.1× 308 2.9× 26 0.3× 34 1.3k
Donna L. Dehn United States 13 36 0.2× 714 4.1× 48 0.4× 145 1.3× 11 0.1× 17 1.1k
Haijun Yu China 17 29 0.2× 335 1.9× 73 0.6× 272 2.5× 37 0.5× 54 777

Countries citing papers authored by Antje Rottmann

Since Specialization
Citations

This map shows the geographic impact of Antje Rottmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antje Rottmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antje Rottmann more than expected).

Fields of papers citing papers by Antje Rottmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antje Rottmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antje Rottmann. The network helps show where Antje Rottmann may publish in the future.

Co-authorship network of co-authors of Antje Rottmann

This figure shows the co-authorship network connecting the top 25 collaborators of Antje Rottmann. A scholar is included among the top collaborators of Antje Rottmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antje Rottmann. Antje Rottmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Schulz, Simone I., et al.. (2024). Mass Balance Recovery, Absorption, Metabolism, and Excretion of Elinzanetant in Healthy Human Volunteers and in vitro Biotransformation. European Journal of Drug Metabolism and Pharmacokinetics. 50(1). 91–103. 1 indexed citations
3.
Hilpert, Jan, Laura Bennett, Catriona L. K. Barnes, et al.. (2023). Hepatotoxicity of AKR1C3 Inhibitor BAY1128688: Findings from an Early Terminated Phase IIa Trial for the Treatment of Endometriosis. Drugs in R&D. 23(3). 221–237. 10 indexed citations
4.
5.
Reif, Stefanie, Isabel Piel, Karsten Denner, et al.. (2023). Mass Balance and Metabolic Pathways of Eliapixant, a P2X3 Receptor Antagonist, in Healthy Male Volunteers. European Journal of Drug Metabolism and Pharmacokinetics. 49(1). 71–85. 1 indexed citations
6.
Chattopadhyay, Niladri, et al.. (2022). Preclinical and Clinical Pharmacokinetics and Bioavailability in Healthy Volunteers of a Novel Formulation of the Selective P2X3 Receptor Antagonist Eliapixant. European Journal of Drug Metabolism and Pharmacokinetics. 48(1). 75–87. 4 indexed citations
7.
Ploeger, Bart A., et al.. (2021). Clinical Pharmacokinetics and Pharmacodynamics of the Selective Progesterone Receptor Modulator Vilaprisan: A Comprehensive Overview. Clinical Pharmacokinetics. 61(1). 1–16. 4 indexed citations
8.
Berger, Markus, Ekkehard May, Hartmut Rehwinkel, et al.. (2020). Discovery of the potent non-steroidal glucocorticoid receptor modulator BAY 1003803 as clinical candidate. Bioorganic & Medicinal Chemistry Letters. 30(16). 127298–127298. 4 indexed citations
9.
Nagel, Jens, Olaf Peters, Antonius ter Laak, et al.. (2019). Identification of a Benzimidazolecarboxylic Acid Derivative (BAY 1316957) as a Potent and Selective Human Prostaglandin E2 Receptor Subtype 4 (hEP4-R) Antagonist for the Treatment of Endometriosis. Journal of Medicinal Chemistry. 62(5). 2541–2563. 18 indexed citations
10.
Möller, Carsten, Wilhelm Bone, Arwed Cleve, et al.. (2018). Discovery of Vilaprisan (BAY 1002670): A Highly Potent and Selective Progesterone Receptor Modulator Optimized for Gynecologic Therapies. ChemMedChem. 13(21). 2271–2280. 26 indexed citations
11.
Höchel, Joachim, Olaf Prien, Torsten Zimmermann, et al.. (2018). Characterization of the Pharmacokinetics of Vilaprisan: Bioavailability, Excretion, Biotransformation, and Drug–Drug Interaction Potential. Clinical Pharmacokinetics. 57(8). 1001–1015. 25 indexed citations
12.
Roivainen, Anne, Esa Kähkönen, Pauliina Luoto, et al.. (2013). Plasma Pharmacokinetics, Whole-Body Distribution, Metabolism, and Radiation Dosimetry of 68Ga Bombesin Antagonist BAY 86-7548 in Healthy Men. Journal of Nuclear Medicine. 54(6). 867–872. 92 indexed citations
13.
Höchel, Joachim, et al.. (2008). Determination of rat serum esterase activities by an HPLC method using S-acetylthiocholine iodide and p-nitrophenyl acetate. Analytical Biochemistry. 381(1). 113–122. 18 indexed citations
14.
Jost, Lorenz, Hans-Peter Gschwind, T. Jalava, et al.. (2006). Metabolism and Disposition of Vatalanib (PTK787/ZK-222584) in Cancer Patients. Drug Metabolism and Disposition. 34(11). 1817–1828. 60 indexed citations
15.
16.
Rottmann, Antje, Erich Kleinpeter, Klaus‐Dieter Spindler, et al.. (2002). SYNTHESIS AND CONFORMATIONAL ANALYSIS OF PSEUDOSUGAR ANALOGUES OF CHITOTRIOSE *. Journal of Carbohydrate Chemistry. 21(6). 471–489. 5 indexed citations
17.
Norledge, B.V., Anne‐Marie Lambeir, Ruben Abagyan, et al.. (2001). Modeling, mutagenesis, and structural studies on the fully conserved phosphate-binding loop (Loop 8) of triosephosphate isomerase: Toward a new substrate specificity. Proteins Structure Function and Bioinformatics. 42(3). 383–389. 25 indexed citations
18.
Rottmann, Antje, et al.. (1999). Synthesis ofN-Acetylglucosaminyl and Diacetylchitobiosyl Amides of Heterocyclic Carboxylic Acids as Potential Chitinase Inhibitors. European Journal of Organic Chemistry. 1999(9). 2293–2297. 11 indexed citations
19.
Rottmann, Antje & Jürgen Liebscher. (1996). Synthesis of enantiomerically pure ω-amino acids by asymmetric α-alkylation of chiral ω-aminoalkyloxazolines. Tetrahedron Letters. 37(3). 359–362. 4 indexed citations
20.
Rottmann, Antje & Jürgen Liebscher. (1996). Chiral 2-(?-Aminoalkyl)-oxazolines by ring transformation of lactam derivatives. Journal für praktische Chemie. 338(1). 397–402. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yi‐Ru Chen Breakdown of academic impact, for papers by Alex Philchenkov Breakdown of academic impact, for papers by J Sedlák Breakdown of academic impact, for papers by Bianca Nitzsche Breakdown of academic impact, for papers by Smarajit Pal Breakdown of academic impact, for papers by Chenghua Li Breakdown of academic impact, for papers by Rajeshwari R. Mehta Breakdown of academic impact, for papers by Donna L. Dehn Breakdown of academic impact, for papers by Haijun Yu
Rankless by CCL
2026